Filing Details

Accession Number:
0001465826-13-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-19 21:21:14
Reporting Period:
2013-11-14
Filing Date:
2013-11-19
Accepted Time:
2013-11-19 21:21:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1053369 Elite Pharmaceuticals Inc ELTP Pharmaceutical Preparations (2834) 223542636
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465822 Jeenarine Narine C/O Epic Pharma, Llc
227-15 North Conduit Avenue
Laurelton NY 11413
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-11-14 465,090 $0.12 16,133,379 No 4 S Indirect By Epic Investments, LLC
Common Stock Disposition 2013-11-15 318,050 $0.12 16,063,408 No 4 S Indirect By Epic Investments, LLC
Common Stock Disposition 2013-11-18 1,170,000 $0.12 15,806,008 No 4 S Indirect By Epic Investments, LLC
Common Stock Disposition 2013-11-19 21,000 $0.12 15,801,388 No 4 S Indirect By Epic Investments, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Epic Investments, LLC
No 4 S Indirect By Epic Investments, LLC
No 4 S Indirect By Epic Investments, LLC
No 4 S Indirect By Epic Investments, LLC
Footnotes
  1. Jeenarine Narine is an equity owner and executive officer of each of Epic Investments, LLC (EI)and Epic Pharma, LLC (EP), which is a 10% owner of the issuer, and also serves as a director of the issuer.
  2. Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.